Pharmacology review: Lidocaine for neonatal seizure management

NeoReviews

Volumn 9, Issue 12, 2008, Pages

  Rademaker, Carin M A ^a   de Vries, Linda S ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77149169781     PISSN: None     EISSN: 15269906     Source Type: Journal    
DOI: 10.1542/neo.9-12-e585     Document Type: Article

References (37)

1. Volpe J. Neonatal seizures. In: Neurology of the Newborn. 5th ed. Philadelphia, Pa: WB Saunders Co; 2008:203-244
2. Hellström-Westas L, Rosén I, de Vries LS, Greisen G. Amplitude-integrated EEG classification and interpretation in preterm and term infants. NeoReviews. 2006; 7: e76-e86
3. Scher MS, Alvin J, Gaus L, Minnigh B, Painter MJ. Uncoupling of EEG-clinical neonatal seizures after antiepileptic drug use. Pediatr Neurol. 2003; 28: 277-280
4. Boylan GB, Pressler RM, Rennie JM, et al. Outcome of electroclinical, electro-graphic, and clinical seizures in the newborn infant. Dev Med Child Neurol. 1999; 41: 819-825
5. Painter MJ, Scher MS, Stein AD, et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med. 1999; 341:485-489
6. Rey E, Radvanyi-Bouvet MF, Bodiou C, et al. Intravenous lidocaine in the treatment of convulsions in the neonatal period: monitoring plasma levels. Ther Drug Monit. 1990; 12:316-320
7. Hellström-Westas L, Westgren U, Rosen I, Svenningsen NW. Lidocaine for treatment of severe seizures in newborn infants. I. Clinical effects and cerebral electrical activity monitoring. Acta Paediatr Scand. 1988; 77:79-84
8. Malingre MM, Van Rooij LG, Rademaker CM, et al. Development of an optimal lidocaine infusion strategy for neonatal seizures. Eur J Pediatr. 2006; 165:598-604
9. Hellström-Westas L, Svenningsen NW, Westgren U, Rosen I, Lagerstrom PO. Lidocaine for treatment of severe seizures in newborn infants. II. Blood concentrations of lidocaine and metabolites during intravenous infusion. Acta Paediatr. 1992; 81: 35-39
10. Van Rooij LG, Toet MC, Rademaker KM, Groenendaal F, de Vries LS. Cardiac arrhythmias in neonates receiving lidocaine as anticonvulsive treatment. Eur J Pediatr. 2004; 163:637-641
11. Mihaly GW, Moore RG, Thomas J, Triggs EJ, Thomas D, Shanks CA. The pharmacokinetics and metabolism of the anilide local anaesthetics in neonates. I. Lignocaine. Eur J Clin Pharmacol. 1978; 13: 143-152
12. Orlando R, Piccoli P, De MS, Padrini R, Floreani M, Palatini P. Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function. Clin Pharmacol Ther. 2004; 75: 80-88
13. Wallin A, Nergardh A, Hynning PA. Lidocaine treatment of neonatal convulsions, a therapeutic dilemma. Eur J Clin Pharmacol. 1989; 36:583-586
14. McEvoy GK. Local anesthetics. In: American Hospital Formulary Service Drug Information. Bethesda, Md: American Society of Health-System Pharmacists; 2008: 3317
15. Roden DM. Antiarrhythmic drugs. In: Brunton LL, Lazo GS, Parker KL. eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th ed. New York, NY: McGraw-Hill; 2006:925-926
16. Radvanyi-Bouvet MF, Torricelli A., Rey E, Bavoux F, Walti H. Effects of lidocaine on seizures in the neonatal period: some electroclinical aspects. In: Wasterlain CG, Vert P, eds. Neonatal Seizures. Philadelphia, Pa: Lippincott, Williams & Wilkins; 1990:277-285
17. Sung CY, Truant AP. The physiological disposition of lidocaine and its comparison in some respects with procaine. J Pharmacol Exp Ther. 1954; 112:432-443
18. van Donselaarvan der Pant KA, Buwalda M, van Leeuwen HJ. Lidocaine: local anaesthetic with systemic toxicity [published in Dutch]. Ned Tijdschr Geneeskd. 2008; 152:61-65
19. Rothstein P, Dornbusch J, Shaywitz BA. Prolonged seizures associated with the use of viscous lidocaine. J Pediatr. 1982; 101:461-463
20. Resar LM, Helfaer MA. Recurrent seizures in a neonate after lidocaine administration. J Perinatol. 1998; 18:193-195
21. DeToledo JC. Lidocaine and seizures. Ther Drug Monit. 2000; 22:320-322
22. Ellenhorn MJ, Barceloux DG. Antiarrhythmic agents. Class IB drugs, In: Medical Toxicology. New York, NY: Elsevier Inc; 1988:185
23. Drayer DE, Lorenzo B, Werns S, Reidenberg MM. Plasma levels, protein binding, and elimination data of lidocaine and active metabolites in cardiac patients of various ages. Clin Pharmacol Ther. 1983; 34: 14-22
24. Blumer J, Strong JM, Atkinson AJ Jr. The convulsant potency of lidocaine and its N-dealkylated metabolites. J Pharmacol Exp Ther. 1973; 186:31-36
25. Booth D, Evans DJ. Anticonvulsants for neonates with seizures. Cochrane Database Syst Rev. 2004; 4:CD004218
26. Boylan GB, Rennie JM, Chorley G, et al. Secondline anticonvulsant treatment of neonatal seizures: a video-EEG monitoring study. Neurology. 2004; 62:486-488
27. Yamamoto H, Aihara M, Niijima S, Yamanouchi H. Treatments with midazolam and lidocaine for status epilepticus in neonates. Brain Dev. 2007; 29:559-564
28. Shany E, Benzaqen O, Watemberg N. Comparison of continuous drip of midazolam or lidocaine in the treatment of intractable neonatal seizures. J Child Neurol. 2007; 22:255-259
29. Berger I, Steinberg A, Schlesinger Y, Seelenfreund M, Schimmel MS. Neonatal mydriasis: intravenous lidocaine adverse reaction. J Child Neurol. 2002; 17:400-401
30. Benowitz NL, Meister W. Clinical pharmacokinetics of lignocaine. Clin Pharmacokinet. 1978; 3:177-201
31. Campbell TJ, Williams KM. Therapeutic drug monitoring: antiarrhythmic drugs. Br J Clin Pharmacol. 1998; 46:307-319
32. Lie KI, Wellens HJ, van Capelle FJ, Durrer D. Lidocaine in the prevention of primary ventricular fibrillation. A doubleblind, randomized study of 212 consecutive patients. N Engl J Med. 1974; 291: 1324-1326
33. Gianelly R, von der Groeben JO, Spivack AP, Harrison DC. Effect of lidocaine on ventricular arrhythmias in patients with coronary heart disease. N Engl J Med. 1967; 277:1215-1219
34. Rezvani M, Finkelstein Y, Verjee Z, Railton C, Koren G. Generalized seizures following topical lidocaine administration during circumcision: establishing causation. Paediatr Drugs. 2007; 9:125-127
35. Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005; 353:1574-1584
36. Gluckman PD, Gunn AJ, Wyatt JS. Hypothermia for neonates with hypoxicischemic encephalopathy. N Engl J Med. 2006; 354:1643-1645
37. Tortorici MA, Kochanek PM, Poloyac SM. Effects of hypothermia on drug disposition, metabolism, and response: a focus of hypothermia-mediated alterations on the cytochrome P450 enzyme system. Crit Care Med. 2007; 35:2196-2204